AXQ Capital LP Raises Holdings in Option Care Health, Inc. $OPCH

AXQ Capital LP boosted its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 256.2% during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 40,092 shares of the company’s stock after buying an additional 28,836 shares during the quarter. AXQ Capital LP’s holdings in Option Care Health were worth $1,113,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of OPCH. Durable Capital Partners LP raised its holdings in shares of Option Care Health by 134.2% in the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after acquiring an additional 4,720,988 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its stake in Option Care Health by 109.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock valued at $110,770,000 after purchasing an additional 1,778,279 shares during the last quarter. Norges Bank purchased a new position in Option Care Health in the 2nd quarter valued at about $69,932,000. Jennison Associates LLC boosted its stake in shares of Option Care Health by 145.6% during the 2nd quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock worth $69,450,000 after purchasing an additional 1,267,660 shares during the last quarter. Finally, Swedbank AB purchased a new stake in shares of Option Care Health during the third quarter worth about $49,455,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on OPCH shares. Weiss Ratings reissued a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. National Bank Financial set a $37.00 price target on Option Care Health in a report on Tuesday, January 27th. Jefferies Financial Group restated a “buy” rating and set a $37.00 price objective on shares of Option Care Health in a report on Tuesday, January 13th. Morgan Stanley lifted their price objective on Option Care Health from $35.00 to $38.00 and gave the company an “overweight” rating in a research report on Tuesday, January 13th. Finally, Barrington Research upped their target price on Option Care Health from $38.00 to $42.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $37.58.

Option Care Health Stock Up 1.1%

Shares of NASDAQ OPCH opened at $36.09 on Tuesday. The stock has a market capitalization of $5.73 billion, a PE ratio of 28.64, a P/E/G ratio of 2.13 and a beta of 0.84. The company has a quick ratio of 1.05, a current ratio of 1.56 and a debt-to-equity ratio of 0.85. The firm has a fifty day moving average of $33.97 and a 200-day moving average of $30.47. Option Care Health, Inc. has a 52-week low of $24.24 and a 52-week high of $36.80.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.